Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127572821 | 12757282 | 1 | I | 20160916 | 20160919 | 20160919 | EXP | CA-ROCHE-1831645 | ROCHE | 58.00 | YR | F | Y | 0.00000 | 20160919 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127572821 | 12757282 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous drip | U | 103705 | 1000 | MG | SOLUTION FOR INFUSION | |||||||
| 127572821 | 12757282 | 2 | SS | RITUXAN | RITUXIMAB | 1 | U | 103705 | |||||||||||
| 127572821 | 12757282 | 3 | SS | RITUXAN | RITUXIMAB | 1 | U | 103705 | |||||||||||
| 127572821 | 12757282 | 4 | SS | ACTONEL | RISEDRONATE SODIUM | 1 | Unknown | U | 0 | TABLET | |||||||||
| 127572821 | 12757282 | 5 | SS | IMURAN | AZATHIOPRINE | 1 | Unknown | PRODUCT USED FOR UNKNOWN INDICATION | U | 0 | 100 | MG | |||||||
| 127572821 | 12757282 | 6 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 127572821 | 12757282 | 7 | C | ASACOL | MESALAMINE | 1 | Unknown | 0 | |||||||||||
| 127572821 | 12757282 | 8 | C | DIPHENHYDRAMINE HYDROCHLORIDE. | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127572821 | 12757282 | 9 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | 0 | ||||||||||||
| 127572821 | 12757282 | 10 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 0 | ||||||||||||
| 127572821 | 12757282 | 11 | C | ONE ALPHA | ALFACALCIDOL | 1 | 0 | ||||||||||||
| 127572821 | 12757282 | 12 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 127572821 | 12757282 | 13 | C | PREDNISONE. | PREDNISONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127572821 | 12757282 | 1 | Hypersensitivity vasculitis |
| 127572821 | 12757282 | 2 | Colitis ulcerative |
| 127572821 | 12757282 | 3 | Cholangitis sclerosing |
| 127572821 | 12757282 | 4 | Product used for unknown indication |
| 127572821 | 12757282 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127572821 | 12757282 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127572821 | 12757282 | Arthritis | |
| 127572821 | 12757282 | Off label use | |
| 127572821 | 12757282 | Osteoporosis | |
| 127572821 | 12757282 | Sepsis | |
| 127572821 | 12757282 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |